Resources Year All 2019 2018 2017 2016 2015 2014 2013 2012 2010 Go Search Presentation High Throughput Screen to Evaluate Combinations With Ibrutinib in Various B-Cell Malignancies PDF (213.46 KB) Read MorePresentation Nuclear export inhibitor selinexor (KPT-330) demonstrates anti-tumor efficacy alone and in combination with chemotherapy in multiple breast cancer models PDF (589.47 KB) Read MorePresentation Assessing combinations of chemotherapy agents in Alveolar Soft Part Sarcoma cell lines PDF (1.89 MB) Read MorePresentation Melphalan and XPO1 Inhibition are Synergistic in Pre-Clinical Models of Multiple Myeloma PDF (266.69 KB) Read MorePaper First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors External Link Read MorePresentation Phase 1 Study of Safety and Tolerability of Selinexor in Asian Patients with Advanced Solid Cancers PDF (772.77 KB) Read MorePaper A Method for Quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds PDF (4.05 MB) Read MorePresentation Selinexor, ARA-C and Idarubicin: An effective and tolerable combination in patients with relapsed, refractory AML: A multicenter phase II study PDF (318.03 KB) Read MorePresentation Phase 1 MMRC Trial of Selinexor, Carfilzomib (CFZ), and Dexamethasone (DEX) in Relapsed and Relapsed/Refractory Multiple Myeloma PDF (3.98 MB) Read MorePresentation Nuclear Export Inhibitor KPT-8602 Is Highly Active Against Leukemic Blasts and Leukemia-Initiating Cells in Patient-Derived Xenograft Models of AML PDF (923.48 KB) Read More Previous 1 … 10 11 12 13 14 … 22 Next